Capital

2108, 2023

COMPASS Pathways Q2 2023 Financial Analysis

LOS ANGELES-- COMPASS Pathways, a biotech firm in the psychedelic medicine sector, has been under the spotlight since its inception. This year, the company's trajectory remains ...

1708, 2023
  • Curaleaf Holdings, Inc.

Curaleaf Holdings Inc. Reports Q2 2023

NEW YORK — Curaleaf Holdings Inc., a global provider of consumer cannabis products, has released its Q2 2023 financial results. The company has reported a 4% ...

Go to Top